fda compounding semaglutide warning september 2025 Safe use of compounded GLP products Beyond the Headlines: FDA Warning
Description
Many athletes in larger bodies report that they are: Pressured to lose weight, even while training and racing at high levels Dismissed or misdiagnosed by healthcare providers Told their body is a problem, even when their habits and health markers are solid This matters because weight is not the sole determinant of health or performance

It's a hormone your body naturally produces that can help regulate blood sugar and appetite

10.1016/j.bbrc.2009.01.003 172

Order requests are reviewed by the research team and quoted privately

Studies suggest that hair loss affects approximately 1 in 20 people taking GLP-1 medications, and while it is often temporary, it can be deeply distressing
